Malaysian Genomics Resource (0155) — Capital Reinvestment Ratio
Malaysian Genomics Resource (0155) has a Capital Reinvestment Ratio of 0.08x as of December 2025, meaning it reinvests 0% of its operating cash flow (RM960.00K) in capital expenditures (RM72.00K). See 0155 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Malaysian Genomics Resource Capital Reinvestment Ratio (2015–2022)
This chart tracks Malaysian Genomics Resource's Capital Reinvestment Ratio across 5 annual periods. Check Malaysian Genomics Resource (0155) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Malaysian Genomics Resource (2015–2022)
Year-by-year Capital Reinvestment Ratio for Malaysian Genomics Resource from 2015 to 2022. For live market cap and broader valuation context, see 0155 company net worth.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 23.38x | RM56.92K | RM1.33 Million | ▲ +77574.7% |
| 2020 | 0.03x | RM11.67 Million | RM351.18K | ▼ -22.9% |
| 2017 | 0.04x | RM3.67 Million | RM143.49K | ▼ -20.7% |
| 2016 | 0.05x | RM3.68 Million | RM181.42K | ▼ -93.9% |
| 2015 | 0.80x | RM395.83K | RM318.34K | — |